Evidence map›Paper›PMID 40833486›Full record

ReviewDrug delivery and translational research2025

Plant-derived exosome-like nanovesicles: mechanisms and molecular understanding in neurological disorders with potential therapeutic applications.

Sevim Isik, Sedra Alhelwani, Aya Sahsahi, Hilal Balcilar, Bercem Yeman-Kiyak

Abstract readReview
In one paragraph

Review in Drug delivery and translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sevim IsikDepartment of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Uskudar University, Uskudar, Istanbul, 34662, Türkiye. sevim.isik@uskudar.edu.tr.ORCID 0000-0001-7687-6082
Sedra AlhelwaniStem Cell Research and Application Center (USKOKMER), Uskudar University, Uskudar, Istanbul, 34662, Türkiye.ORCID 0009-0003-8130-4136
Aya SahsahiStem Cell Research and Application Center (USKOKMER), Uskudar University, Uskudar, Istanbul, 34662, Türkiye.ORCID 0009-0006-7406-1131
Hilal BalcilarDepartment of Molecular Biology, Institute of Science, Uskudar University, Uskudar, Istanbul, 34662, Türkiye.ORCID 0009-0005-7605-6611
Bercem Yeman-KiyakStem Cell Research and Application Center (USKOKMER), Uskudar University, Uskudar, Istanbul, 34662, Türkiye.ORCID 0000-0001-9667-3506

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes are nano vesicles secreted by the cells that play an essential role in intercellular communication, enabling the transport of bioactive molecules, including proteins, lipids, and nucleic acids. Among them, plant-derived exosome-like nanovesicles have attracted considerable interest due to their prospective therapeutic implications, especially for neurological disorders. This article provides an overview of the biogenesis of plant-derived exosome-like nanovesicles, compares their characteristics with mammalian-derived exosomes, and investigates their bioavailability and chemical composition. The article also discusses the mechanisms through which they are uptaken by cells, highlighting several cellular uptake pathways and their significance for targeted drug delivery. Moreover, it explains the molecular basis of neurological disorders and investigates how plant-derived exosome-like nanovesicles regulate intracellular signaling pathways, providing potential therapeutic benefits. Finally, it provides the latest advancements in engineering research, emphasizing biochemical modifications on the exosomal surface, loading therapeutic molecules into exosomes, and exosomes derived from genetically engineered plants, for more effective therapies in neurological disorders.

Indexed as

ExosomesNervous System DiseasesPlantsAnimalsDrug Delivery SystemsHumansAlzheimer's diseaseEngineered exosomesNeurological disordersParkinson's diseasePersonalized medicinePlant-derived exosome-like nanovesicles

Identifiers

PMID40833486
PMCPMC12619726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.